SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 25,085.60 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 10,029.00 |
| Book Value / Share | 52.77 |
| Price / Book | n/a |
| NCAV ($M) | -2,530.00 |
| NCAV / Share | -13.31 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.08 |
| Return on Assets (ROA) | 0.07 |
| Return on Equity (ROE) | 0.12 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.99 |
| Current Ratio | 1.36 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4,788.00 |
| Assets | 17,347.00 |
| Liabilities | 7,318.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 6,152.00 |
| Operating Income | 836.00 |
| Net Income | 1,065.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 1,242.00 |
| Cash from Investing | 282.00 |
| Cash from Financing | -818.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| TRGNF – Transgene SA | TRVN – Trevena, Inc. |
| TSMRF – Tsumura & Co. | UNBSF – Uni-Bio Science Group Limited |
| VAXX – Vaxxinity, Inc. |
Financial data and stock pages provided by
Fintel.io